---
title: "在医疗保险排除减肥药物覆盖后，礼来和诺和诺德公司的股票暴跌。特朗普政府的新政策未将它们纳入覆盖范围"
description: "周五，特朗普政府宣布了最终的医疗保险和医疗补助政策，导致礼来股票下跌。减肥药物的排除使得礼来和诺和诺德公司的股票大幅下滑。该决定对市场产生了重大影响，礼来的股票价值明显下降"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/234617274.md"
published_at: "2025-04-04T22:52:16.000Z"
---

# 在医疗保险排除减肥药物覆盖后，礼来和诺和诺德公司的股票暴跌。特朗普政府的新政策未将它们纳入覆盖范围

> 周五，特朗普政府宣布了最终的医疗保险和医疗补助政策，导致礼来股票下跌。减肥药物的排除使得礼来和诺和诺德公司的股票大幅下滑。该决定对市场产生了重大影响，礼来的股票价值明显下降

周五，特朗普政府宣布了最终的医疗保险和医疗补助政策，导致礼来公司的股票下跌。减肥药的排除导致礼来和诺和诺德公司的股票大幅下滑。该决定对市场产生了重大影响，礼来的股票价值明显下降。

### Related Stocks

- [NVO.US - 诺和诺德公司](https://longbridge.com/zh-CN/quote/NVO.US.md)
- [LLY.US - 礼来](https://longbridge.com/zh-CN/quote/LLY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Novo files patent suit against Hims & Hers over Wegovy knockoffs | Novo files patent suit against Hims & Hers over Wegovy knockoffs | [Link](https://longbridge.com/zh-CN/news/275316277.md) |
| Novo Nordisk A/S repurchases units for DKK 222 million | Novo Nordisk A/S has repurchased 750,000 B shares for approximately DKK 222 million at an average price of 296.40 DKK pe | [Link](https://longbridge.com/zh-CN/news/275315124.md) |
| Novo Nordisk Launches Weight Loss Pill Across US | Novo Nordisk Launches Weight Loss Pill Across US | [Link](https://longbridge.com/zh-CN/news/274912821.md) |
| Novo Nordisk CEO Mike Doustdar Plans To Bring "Wegovy High-Dose" To Market As Soon As Possible - CNBC Interview | NOVO NORDISK CEO MIKE DOUSTDAR: PLANS TO BRING "WEGOVY HIGH-DOSE" TO THE MARKET AS SOON AS POSSIBLE- CNBC INTERVIEW | [Link](https://longbridge.com/zh-CN/news/274884174.md) |
| Novo Nordisk Says FDA Approves Ozempic Pill, Set to be Available in US in Q2 | Novo Nordisk Says FDA Approves Ozempic Pill, Set to be Available in US in Q2 | [Link](https://longbridge.com/zh-CN/news/274849748.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。